CVR 57537728Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)ÅlsgårdeFounded 24 May 1976
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about HOLM CHRISTENSEN BIOSYSTEMER ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, 2024
Gross profit
4.9M
DKK, annual report 2025
+4,284% on 2024
Result
+2.6M
DKK, annual report 2025
Equity
4.5M
DKK, annual report 2025
Lena Holm Christensen33.3% to under 50% of capital and votes, since 21 Dec 2011
Birgitte Holm Christensen33.3% to under 50% of capital and votes, since 21 Dec 2011
and 1 moreOperating company
Dandex estimate: revenue or gross profit in the 2025 reportBirgitte Holm Christensensince 9 Nov 2020
33.3% to under 50% of capital and votessince 21 Dec 2011
10% to under 15% of capital and votesnotified 3 Dec 2020since 21 Dec 2011
33.3% to under 50% of capital and votessince 21 Dec 2011
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
5% to under 10% of capital and votes21 Dec 2011 to 3 Oct 2020
3 Danish companies.
SubsidiaryCVR 31470757100% of capital and votes
SubsidiaryCVR 29769699100% of capital and votes
CVR 2689053525% to under 33.3% of capital and votes
Found by searching the CVR owner register (ejerregister) for HOLM CHRISTENSEN BIOSYSTEMER ApS as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
Decided by Dandex with fixed rules from CVR and the filed annual reports, not registered by the company. Each label links to its definition.
24 May 1976 to 11 Nov 2026.
Dec 2024, monthly: 1 employee, 0 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | No count | No count | No count | No count | 2 | 2 | 3 | 3 | 4 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 4 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 4 | 2 | 3 | 2 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 4 | 2 | 3 | 4 | 4 | 3 | 4 | 3 | 4 | 2 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| FTE | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Series | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 1997 to 2009 and 2011 to 2014; quarterly Q1 2010 to Q4 2010; monthly Jan 2015 to Dec 2024.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Dec 2024, published 20 Feb 2025. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 118 | 79 | 95 | 111 | 4,873 |
| Result for the year | -951 | -1,378 | -905 | -673 | +2,554 |
| Equity | 5,051 | 3,547 | 2,642 | 1,969 | 4,523 |
| Total assets | 14,951 | 12,980 | 13,131 | 12,736 | 17,421 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 1 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | -98.6% | -33.6% | 20.7% | 17.2% | 4,284% |
| EBITDA | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | 3,057note 2 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | Not reportednote 3 | Not reportednote 3 | Not reportednote 3 | Not reportednote 3 | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 0note 4 | 0note 4 | 0note 4 | 0note 4 | Not reportednote 5 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2025
1 Jul 2024 to 30 Jun 2025, published 25 Nov 2025
Annual report 2024
1 Jul 2023 to 30 Jun 2024, published 11 Dec 2024
Annual report 2023
1 Jul 2022 to 30 Jun 2023, published 19 Dec 2023
Annual report 2022
1 Jul 2021 to 30 Jun 2022, published 29 Sep 2022
Annual report 2021
1 Jul 2020 to 30 Jun 2021, published 1 Nov 2021
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For HOLM CHRISTENSEN BIOSYSTEMER ApS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 11 Nov 2026. Text such as the signing rule and purpose is shown as registered.
12 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Vedtægter ændret: 11.12.2024
Revision:
Fratrådte:
REVISIONSFIRMAET TORLUND, STATSAUTORISERET REVISIONSANPARTSSELSKAB, den 11.12.2024.
Direktion:
Fratrådte:
Børge Holm Christensen, den 09.11.2020.
Tiltrådte:
Birgitte Holm Christensen, den 09.11.2020.
Revision:
Udtrådt af revisionen:
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 06.07.2012.
Indtrådt i revisionen:
CVR-NR. 31165571 REVISIONSFIRMAET TORLUND, STATSAUTORISERET REVISIONSANPARTSSELSKAB, Langebjergvænget 10A, 1., 4000 Roskilde, den 06.07.2012.
Vedtægter ændret:
21.12.2011.
Revision:
Udtrådt af revisionen:
DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB, den 13.10.2011.
Indtrådt i revisionen:
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, Egtved Allé 4, 6000 Kolding, den 13.10.2011.
Revision:
Udtrådt af revisionen:
Revisionsfirmaet B. Kærsgaard Laursen I/S, den 30.12.1997.
Indtrådt i revisionen:
DELOITTE & TOUCHE STATSAUTORISERET REVISIONSAKTIESELSKAB, Buen 6-8, Postboks 29, 6000 Kolding, den 30.12.1997.
Vedtægter ændret:
11.12.1996.
Kapitalforhøjelse:
kr. 120.000,00 indbetalt ved overførte reserver / overskud, kurs 100,00.
Kapitalen udgør herefter kr. 200.000,00.
Ny adresse:
Odinshøjvej 116, 3140 Ålsgårde
Revision:
Udtrådt af revisionen:
Revisionsfirmaet Schøbel & Marholt
Indtrådt i revisionen:
REVISIONSFIRMAET B. KÆRSGAARD LAURSEN I/S, Hovedgaden 28, 2970 Hørsholm
Vedtægter ændret:
29.12.1986
Kapitalforhøjelse:
kr. 50.000,00 indbetalt i værdier, kurs 100,0
Kapitalen udgør herefter kr. 80.000,00
REG.NR. ApS14685
NAVN: HOLM CHRISTENSEN BIOSYSTEMER ApS
ADRESSE: Odinsvej 116, 3140 Ålsgårde
Stiftelsesdato:
24.05.1976
Seneste vedtægtsdato:
21.12.1976
Kapital:
kr. 30.000,00
Indbetalingsmåde:
kontant/i værdier kr. 30.000,00 til kurs 100,0
Direktion:
Civilingeniør Børge Holm Christensen, Civilingeniør Inger Lise Christensen
Selskabet tegnes af direktionen
Revision:
Schøbel & Marholt, 6000 Kolding
Første regnskabsår:
00.00 - 00.00
Regnskabsår:
01.07 - 30.06
1 registered in CVR.
P-number 1002064230Odinshøjvej 116, 3140 Ålsgårde
